Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 3
1975 3
1976 9
1977 5
1978 3
1979 1
1980 10
1981 7
1982 10
1983 3
1984 10
1985 7
1986 9
1987 4
1988 10
1989 11
1990 15
1991 5
1992 13
1993 12
1994 13
1995 18
1996 15
1997 16
1998 15
1999 18
2000 26
2001 25
2002 20
2003 22
2004 26
2005 26
2006 31
2007 35
2008 35
2009 37
2010 41
2011 45
2012 39
2013 46
2014 50
2015 42
2016 57
2017 46
2018 39
2019 47
2020 48
2021 50
2022 51
2023 51
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

1,080 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Breast Carcinoma in the Skin"
Page 1
Manual lymphatic drainage for lymphedema following breast cancer treatment.
Ezzo J, Manheimer E, McNeely ML, Howell DM, Weiss R, Johansson KI, Bao T, Bily L, Tuppo CM, Williams AF, Karadibak D. Ezzo J, et al. Cochrane Database Syst Rev. 2015 May 21;2015(5):CD003475. doi: 10.1002/14651858.CD003475.pub2. Cochrane Database Syst Rev. 2015. PMID: 25994425 Free PMC article. Review.
BACKGROUND: More than one in five patients who undergo treatment for breast cancer will develop breast cancer-related lymphedema (BCRL). ...SEARCH METHODS: We searched Medline, EMBASE, CENTRAL, WHO ICTRP (World Health Organization's International Clinical …
BACKGROUND: More than one in five patients who undergo treatment for breast cancer will develop breast cancer-related lymphede …
Manual lymphatic drainage therapy in patients with breast cancer related lymphoedema.
Martín ML, Hernández MA, Avendaño C, Rodríguez F, Martínez H. Martín ML, et al. BMC Cancer. 2011 Mar 9;11:94. doi: 10.1186/1471-2407-11-94. BMC Cancer. 2011. PMID: 21392372 Free PMC article. Clinical Trial.
METHODS: A randomized, controlled clinical trial in 58 women with post-mastectomy lymphoedema. The control group includes 29 patients with standard treatment (skin care, exercise and compression measures, bandages for one month and, subsequently, compr …
METHODS: A randomized, controlled clinical trial in 58 women with post-mastectomy lymphoedema. The control group includ …
Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial.
Behroozian T, Milton L, Karam I, Zhang L, Ding K, Lou J, Gallant F, Rakovitch E, Tran W, Soliman H, Leung E, Vesprini D, Szumacher E, Chen H, Donovan E, Lam J, Spadafora S, Wronski M, Lavoie C, Walde N, Lam E, Wong G, McKenzie E, Ariello K, Kennedy S, Shariati S, Carothers K, Gonzales G, Kagan Y, Chow E. Behroozian T, et al. J Clin Oncol. 2023 Feb 20;41(6):1250-1264. doi: 10.1200/JCO.22.01873. Epub 2022 Dec 9. J Clin Oncol. 2023. PMID: 36493331 Clinical Trial.
PURPOSE: Radiation dermatitis (RD) is common in patients undergoing breast radiotherapy. Mepitel film (MF) can reduce RD, but the results from two randomized controlled trials are conflicting. We aimed to conduct a confirmatory randomized controlled trial …
PURPOSE: Radiation dermatitis (RD) is common in patients undergoing breast radiotherapy. Mepitel film (MF) can reduce RD, but the res …
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S, Jimenez M, Isambert N, Peyrade F, Chevreau C, Bompas E, Brain EG, Blay JY. Penel N, et al. J Clin Oncol. 2008 Nov 10;26(32):5269-74. doi: 10.1200/JCO.2008.17.3146. Epub 2008 Sep 22. J Clin Oncol. 2008. PMID: 18809609 Clinical Trial.
PURPOSE: The objective of this phase II trial was to assess the efficacy and toxicity of weekly paclitaxel for patients with metastatic or unresectable angiosarcoma. ...The progression-free survival rate was similar in patients pretreated with chemotherapy and in ch …
PURPOSE: The objective of this phase II trial was to assess the efficacy and toxicity of weekly paclitaxel for patients with metas …
Skin-sparing mastectomy for the treatment of breast cancer.
Mota BS, Bevilacqua JLB, Barrett J, Ricci MD, Munhoz AM, Filassi JR, Baracat EC, Riera R. Mota BS, et al. Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD010993. doi: 10.1002/14651858.CD010993.pub2. Cochrane Database Syst Rev. 2023. PMID: 36972145 Free PMC article. Review.
BACKGROUND: Skin-sparing mastectomy (SSM) is a surgical technique that aims to maximize skin preservation, facilitate breast reconstruction, and improve cosmetic outcomes. ...SELECTION CRITERIA: Randomized controlled trials (RCTs), quasi-randomized …
BACKGROUND: Skin-sparing mastectomy (SSM) is a surgical technique that aims to maximize skin preservation, facilitate breas …
Synthesis and Clinical Development of Palbociclib: An Overview.
Konar D, Maru S, Kar S, Kumar K. Konar D, et al. Med Chem. 2022;18(1):2-25. doi: 10.2174/1573406417666201204161243. Med Chem. 2022. PMID: 33280599 Review.
Breast cancer is the second most commonly identified cancer in women in the United States after skin cancer. ...This has directed the search for newer drug therapies to target advanced breast cancer and resistance. One of these efforts has resulted in the dev …
Breast cancer is the second most commonly identified cancer in women in the United States after skin cancer. ...This has direc …
Lapatinib in breast cancer.
Bilancia D, Rosati G, Dinota A, Germano D, Romano R, Manzione L. Bilancia D, et al. Ann Oncol. 2007 Jun;18 Suppl 6:vi26-30. doi: 10.1093/annonc/mdm220. Ann Oncol. 2007. PMID: 17591827 Free article. Review.
Phase I clinical trials have shown also that lapatinib is well tolerated, with mild diarrhea and skin rush as common toxic effects and low incidence of cardiotoxicity. Phase II and III clinical trials' data provide encouraging evidence of the clinical …
Phase I clinical trials have shown also that lapatinib is well tolerated, with mild diarrhea and skin rush as common toxic eff …
Quantity of Acellular Dermal Matrix in Immediate Breast Reconstruction and Outcomes.
Driscoll CR, Prabhu SS, Davidson AL, Katz AJ. Driscoll CR, et al. Ann Plast Surg. 2022 Jun 1;88(5 Suppl 5):S410-S413. doi: 10.1097/SAP.0000000000003121. Epub 2022 Feb 18. Ann Plast Surg. 2022. PMID: 35690935
PURPOSE: This study aimed to determine the impact of the quantity of acellular dermal matrix (ADM), "ADM burden," used in implant-based breast reconstruction on infection, drain duration, and seroma formation. ...CONCLUSIONS: Higher ADM burden is associated with an increas …
PURPOSE: This study aimed to determine the impact of the quantity of acellular dermal matrix (ADM), "ADM burden," used in implant-based b …
Small extracellular vesicles: from promoting pre-metastatic niche formation to therapeutic strategies in breast cancer.
Chen X, Feng J, Chen W, Shao S, Chen L, Wan H. Chen X, et al. Cell Commun Signal. 2022 Sep 12;20(1):141. doi: 10.1186/s12964-022-00945-w. Cell Commun Signal. 2022. PMID: 36096820 Free PMC article. Review.
Breast cancer is the most common cancer in females, and to date, the mortality rate of breast cancer metastasis cannot be ignored. The metastasis of breast cancer is a complex, staged process, and the pattern of metastatic spread is not random. …
Breast cancer is the most common cancer in females, and to date, the mortality rate of breast cancer metastasis cannot be igno …
The Use of Tumescent Technique in Mastectomy and Related Complications: A Meta-Analysis.
Siotos C, Aston JW, Euhus DM, Seal SM, Manahan MA, Rosson GD. Siotos C, et al. Plast Reconstr Surg. 2019 Jan;143(1):39-48. doi: 10.1097/PRS.0000000000005100. Plast Reconstr Surg. 2019. PMID: 30589774
The authors included studies on the use of tumescent technique in the context of mastectomy with or without immediate breast reconstruction. The primary outcome the authors evaluated was the rate of skin flap necrosis; the secondary outcomes were the rates of …
The authors included studies on the use of tumescent technique in the context of mastectomy with or without immediate breast reconstr …
1,080 results